Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1976 Feb;56(2):169–178. doi: 10.1111/j.1476-5381.1976.tb07439.x

Dual effect of alpha-adrenoceptor antagonists in rat isolated vas deferens.

A Jurkiewicz, N H Jurkiewicz
PMCID: PMC1666875  PMID: 3246

Abstract

1 In rat isolated vas deferens, the isotonic contractile responses to low doses of noradrenaline or adrenaline were antagonized, and those to high doses were potentiated, by yohimbine, piperoxan, phentolamine and tolazoline. Effects due to intermediate doses were not affected, or were potentiated within about 30 min, following an initial inhibition. 2 The alpha-adrenoceptor blockers thus caused a shift to the right and an increase of the maximum height of log dose-response curves of alpha-adrenoceptor stimulants. For a given dose of antagonist, the onset was slower for the potentiating than for the blocking effect. 3 The shift to the right induced by piperoxan and yohimbine on dose-response curves of noradrenaline and adrenaline was analysed with the Schild plot, and the slopes obtained, around 0.3, were lower than expected from receptor theory. When cocaine was used to block neuronal uptake, the slopes were close to 1.0. 4 The increase in maximum response to noradrenaline and adrenaline induced by alpha-adrenoceptor blockers was dependent on the time of incubation, on the dose of antagonist, and on the initial height of responses to the agonist. A less pronounced potentiation was also obtained when acetylcholine was used as agonist. 5 The findings are explained in terms of receptor theory as being due to a dual effect of alpha-adrenoceptor antagonists; competitive antagonism proper, which may be disclosed after blockade of neuronal uptake, and an interaction at a different locus, which results in potentiation of the effects of noradrenaline and adrenaline.

Full text

PDF
172

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ariëns E. J. The structure-activity relationships of beta adrenergic drugs and beta adrenergic blocking drugs. Ann N Y Acad Sci. 1967 Feb 10;139(3):606–631. doi: 10.1111/j.1749-6632.1967.tb41232.x. [DOI] [PubMed] [Google Scholar]
  2. Barnett A., Greenhouse D. D., Taber R. I. A new type of drug enhancement: increased maximum response to cumulative noradrenaline in the isolated rat vas deferens. Br J Pharmacol Chemother. 1968 May;33(1):171–176. doi: 10.1111/j.1476-5381.1968.tb00485.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Dale H. H., Gaddum J. H. Reactions of denervated voluntary muscle, and their bearing on the mode of action of parasympathetic and related nerves. J Physiol. 1930 Sep 18;70(2):109–144. doi: 10.1113/jphysiol.1930.sp002682. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. EMMELIN N. Supersensitivity following "pharmacological denervation". Pharmacol Rev. 1961 Mar;13:17–37. [PubMed] [Google Scholar]
  5. Enero M. A., Langer S. Z. Influence of reserpine-induced depletion of noradrenaline on the negative feed-back mechanism for transmitter release during nerve stimulation. Br J Pharmacol. 1973 Oct;49(2):214–225. doi: 10.1111/j.1476-5381.1973.tb08367.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Evans B., Iwayama T., Burnstock G. Long-lasting supersensitivity of the rat vas deferens to norepinephrine after chronic guanethidine administration. J Pharmacol Exp Ther. 1973 Apr;185(1):60–69. [PubMed] [Google Scholar]
  7. FURCHGOTT R. F. The pharmacology of vascular smooth muscle. Pharmacol Rev. 1955 Jun;7(2):183–265. [PubMed] [Google Scholar]
  8. Fleming W. W. Supersensitivity of the denervated rat diaphragm to potassium: a comparison with supersensitivity in other tissues. J Pharmacol Exp Ther. 1971 Jan;176(1):160–166. [PubMed] [Google Scholar]
  9. Furchgott R. F. Pharmacological characteristics of adrenergic receptors. Fed Proc. 1970 Jul-Aug;29(4):1352–1361. [PubMed] [Google Scholar]
  10. Furness J. B. Transmission to the longitudinal muscle of the guinea-pig vas deferens: The effect of pretreatment with guanethidine. Br J Pharmacol. 1974 Jan;50(1):63–68. doi: 10.1111/j.1476-5381.1974.tb09593.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ganguly D. K., Bhattacharya B. B. Adrenergic beta receptors in vas deferens. Arch Int Pharmacodyn Ther. 1970 Jun;185(2):406–412. [PubMed] [Google Scholar]
  12. Gingsborg B. L., Stephenson R. P. On the simultaneous action of two competitive antagonists. Br J Pharmacol. 1974 Jun;51(2):287–300. doi: 10.1111/j.1476-5381.1974.tb09659.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Iversen L. L., Langer S. Z. Effects of phenoxybenzamine on the uptake and metabolism of noradrenaline in the rat heart and vas deferens. Br J Pharmacol. 1969 Nov;37(3):627–637. doi: 10.1111/j.1476-5381.1969.tb08501.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Janis R. A., Triggle D. J. On the question of subclassification of -adrenoceptors. J Pharm Pharmacol. 1973 Mar;25(3):263–264. doi: 10.1111/j.2042-7158.1973.tb10638.x. [DOI] [PubMed] [Google Scholar]
  15. Jurkiewicz A., Jurkiewicz N. H., Barros G. G., Valle J. R. Relative responsiveness (rho) of pharmacological receptor systems in the rat vas deferens. Pharmacology. 1969;2(2):89–99. doi: 10.1159/000136005. [DOI] [PubMed] [Google Scholar]
  16. Jurkiewicz A., Markus R. P., Picarelli Z. P. Effect of full agonists following calcium deprivation in rat vas deferens. Eur J Pharmacol. 1975 Apr;31(2):292–304. doi: 10.1016/0014-2999(75)90052-7. [DOI] [PubMed] [Google Scholar]
  17. Jurkiewicz N. H., Jurkiewicz A., Valle J. R. Contractile reserve after maximum doses of full agonists on the rat vas deferens. Pharmacology. 1971;5(3):129–144. doi: 10.1159/000136185. [DOI] [PubMed] [Google Scholar]
  18. KIRPEKAR S. M., CERVONI P., FURCHGOTT R. F. Catecholamine content of the cat nicitating membrane following procedures sensitizing it to norepinephrine. J Pharmacol Exp Ther. 1962 Feb;135:180–190. [PubMed] [Google Scholar]
  19. Kalsner S. A new approach to the measurement and classification of forms of supersensitivity of autonomic effector responses. Br J Pharmacol. 1974 Jul;51(3):427–434. doi: 10.1111/j.1476-5381.1974.tb10678.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kasuya Y., Goto K., Hashimoto H., Watanabe H., Munakata H., Watanabe M. Nonspecific denervation supersensitivity in the rat vas deferens "in vitro". Eur J Pharmacol. 1969 Nov;8(2):177–184. doi: 10.1016/0014-2999(69)90074-0. [DOI] [PubMed] [Google Scholar]
  21. Kasuya Y., Goto K. The mechanism of supersensitivity to norepinephrine induced by cocaine in rat isolated vas deferens. Eur J Pharmacol. 1968 Nov;4(4):355–362. doi: 10.1016/0014-2999(68)90019-8. [DOI] [PubMed] [Google Scholar]
  22. Langer S. Z., Trendelenburg U. The effect of a saturable uptake mechanism on the slopes of dose-response curves for sympathomimetic amines and on the shifts of dose-response curves produced by a competitive antagonist. J Pharmacol Exp Ther. 1969 May;167(1):117–142. [PubMed] [Google Scholar]
  23. OHLIN P., STROMBLAD B. C. Observations on the isolated vas deferens. Br J Pharmacol Chemother. 1963 Apr;20:299–306. doi: 10.1111/j.1476-5381.1963.tb01469.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Paton W. D. Adrenergic receptors viewed in light of general receptor theories. Ann N Y Acad Sci. 1967 Feb 10;139(3):632–644. doi: 10.1111/j.1749-6632.1967.tb41233.x. [DOI] [PubMed] [Google Scholar]
  25. Pennefather J. N. A comparison of the responses of the isolated vas deferens of the rat to field stimulation and to noradrenaline added cumulatively and non-cumulatively. Eur J Pharmacol. 1973 Sep;23(3):245–250. doi: 10.1016/0014-2999(73)90090-3. [DOI] [PubMed] [Google Scholar]
  26. SCHILD H. O. Drug antagonism and pAx. Pharmacol Rev. 1957 Jun;9(2):242–246. [PubMed] [Google Scholar]
  27. Starke K. Influence of extracellular noradrenaline on the stimulation-evoked secretion of noradrenaline from sympathetic nerves: evidence for an -receptor-mediated feed-back inhibition of noradrenaline release. Naunyn Schmiedebergs Arch Pharmacol. 1972;275(1):11–23. doi: 10.1007/BF00505064. [DOI] [PubMed] [Google Scholar]
  28. Swedin G. Postnatal development of the mechanical response of the isolated rat vas deferens to nerve stimulation. Acta Physiol Scand. 1972 Feb;84(2):217–223. doi: 10.1111/j.1748-1716.1972.tb05172.x. [DOI] [PubMed] [Google Scholar]
  29. URSILLO R. C., JACOBSON J. POTENTIATION OF NOREPINEPHRINE IN THE ISOLATED VAS DEFERENS OF THE RAT BY SOME CNS STIMULANTS AND ANTIDEPRESSANTS. J Pharmacol Exp Ther. 1965 May;148:247–251. [PubMed] [Google Scholar]
  30. Westfall D. P. Nonspecific supersensitivity of the guinea-pig vas deferens produced by decentralization and reserpine treatment. Br J Pharmacol. 1970 May;39(1):110–120. doi: 10.1111/j.1476-5381.1970.tb09560.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES